Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation

Clinical Transplantation

Volumn 25, Issue 1, 2011, Pages

  Chopra, Teena ^a   Chandrasekar, Pranatharthi ^a   Salimnia, Hossein ^b   Heilbrun, Lance K ^b   Smith, Daryn ^b   Alangaden, George J ^a  

^a Division of Infectious Diseases   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Clostridium difficile infection; Epidemiology; Hematopoietic transplantation

Indexed keywords

BACTERIAL TOXIN; BUSULFAN; CEFEPIME; CYCLOPHOSPHAMIDE; CYTARABINE; IMIPENEM; METRONIDAZOLE; PROTON PUMP INHIBITOR; QUINOLONE; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CHEMOTHERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; EPIDEMIC; FEBRILE NEUTROPENIA; FECES ANALYSIS; FEMALE; FEVER; HOSPITAL PATIENT; HUMAN; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; RECURRENT INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; CLOSTRIDIUM DIFFICILE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; METRONIDAZOLE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; VANCOMYCIN;

EID: 79551695425     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01331.x     Document Type: Article

References (26)

1. Van Kraaij MG, Dekker AW, Verdonck LF et al. Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients. Bone Marrow Transplant 2000: 26: 299.
2. Bobak D, Arfons LM, Creger RJ, Lazarus HM Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplant 2008: 42: 705.
3. Avery R, Pohlman B, Adal K et al. High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients. Bone Marrow Transplant 2000: 25: 67.
4. Tomblyn M, Gordon L, Singhal S et al. Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea. Bone Marrow Transplant 2002: 30: 517.
5. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005: 353: 2433.
6. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006: 12: 409.
7. Kavan P, Sochor M, Nyc O et al. Pseudomembraneous clostridium after autologous bone marrow transplantation. Bone Marrow Transplant 1998: 21: 521.
8. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002: 346: 334.
9. Chakrabarti S, Lees A, Jones SG, Milligan DW. Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant 2000: 26: 871.
10. Gorschluter M, Glasmacher A, Hahn C et al. Clostridium difficile infection in patients with neutropenia. Clin Infect Dis 2001: 33: 786.
11. Arango JI, Restrepo A, Schneider DL et al. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 2006: 37: 517.
12. McDonald LC, Coignard B, Dubberke E et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007: 28: 140.
13. Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S. An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004: 4: 94.
14. Cohen SH, Gerding DN, Johnson S et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010: 31: 431.
15. Bilgrami S, Feingold JM, Dorsky D et al. Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999: 23: 1039.
16. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am J Infect Control 2009: 37: 263.
17. Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008: 46(Suppl 1): S19.
18. Loo VG, Poirier L, Miller MA. et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005: 353: 2442.
19. Peterson LR, Robicsek A. Does my patient have Clostridium difficile infection? Ann Intern Med 2009: 151: 176.
20. Kvach EJ, Ferguson D, Riska PF, Landry ML. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010: 48: 109.
21. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007: 45: 302.
22. Dubberke ER, Reske KA, Srivastava A. et al. Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes. Clin Transplant 2010: 24: 192.
23. Fekety R, McFarland LV, Surawicz CM, Greenberg RN, Elmer GW, Mulligan ME. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997: 24: 324.
24. Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect 2009: 58: 403.
25. Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA. Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol 2005: 26: 680.
26. Delaney JA, Dial S, Barkun A, Suissa S. Antimicrobial drugs and community-acquired Clostridium difficile-associated disease, UK. Emerg Infect Dis 2007: 13: 761.